Braveheart Bio, Inc.

BRVE· Nasdaq

BRVE · Braveheart Bio, Inc. · Thaler

Braveheart Bio, Inc.

BRVE· NasdaqCore metricsCIK 2131524

FollowFollowing

Pharmaceutical preparations565 peers

Last sale: Oct 2, 2026 · +0.38%
Market cap: $1.92B; 90.04M shares
Filings: 46

Price

$21.27

Oct 2, 2026 · IEX last sale

IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$11.13M

Q2 2026

No annual history for this metric yet.

Period	Ended	Value	Kind	Source trail

Braveheart Bio, Inc. · CIK 2131524 · Engraved from SEC EDGAR